Latest Listings And Ipos News

WAM Income Maximiser Limited has reported a profitable first half since its April 2025 IPO, declaring its inaugural fully franked monthly dividend and setting guidance for dividend growth. The company’s diversified portfolio of ASX300 equities and investment grade corporate debt has delivered promising returns, underpinning its income and capital growth objectives.

The ASX has suspended the securities of 36 companies for failing to pay their annual listing fees by the August 21 deadline, with a looming delisting threat if fees remain unpaid by August 28.

Omnia Metals Group Limited has issued a prospectus to list up to 10,000 options, aiming to remove trading restrictions and facilitate secondary market activity. This move follows recent capital raisings and shareholder approvals, positioning the company for enhanced liquidity.

Nyrada Inc. reported a sharp 25% decline in revenues alongside a 248% surge in net losses for the fiscal year ending June 2025, signaling mounting financial pressures for the pharmaceutical developer.

DigitalX Limited has boosted its treasury valuation to A$104 million, driven by a strategic Bitcoin-first approach that now totals nearly 500 BTC. The company aims to more than quadruple its Bitcoin holdings by 2027, underscoring its confidence in digital assets as a core treasury component.

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

Dart Mining NL’s DTMOC securities have been suspended from trading by the ASX due to non-compliance with key listing rules, raising questions about the company’s regulatory standing.

Resolution Minerals has successfully uplisted to the OTCQB Market in the U.S., enhancing access for American investors without issuing new shares. This move aligns with its strategy to tap into growing demand for critical minerals, particularly antimony.

Gladiator Resources has inked a strategic agreement with Apex USA Resources to explore and develop rare earth element tenements in the United States, marking a significant diversification from its Tanzanian uranium projects.

Cynata Therapeutics has entered a five-year At-the-Market Subscription Agreement with Acuity Capital, enabling access to up to $7.5 million in standby equity capital with full discretion over timing and pricing.

Alkane Resources reported a robust FY2025 with a 87% jump in profit after tax to A$33 million, driven by higher gold production and prices. The company also completed a transformative merger with Mandalay Resources, creating a diversified gold and antimony producer.

Zip Co Limited’s FY25 results reveal a powerful US market expansion driving a 147% rise in cash earnings and a strategic Nasdaq dual listing consideration.